MALAT1 and prostate carcinoma: MALAT1 level in colorectal, brain and CNS, breast, liver and head and neck cancer tissues was upregulated compared to normal tissues, whereas low MALAT1 level in breast, colorectal and prostate cancers, leukemia and lymphoma compared with normal tissues was revealed in some data sets (Figure 1(b).